Range Low Price High Price Comment
30 days $36.77 $55.69 Wednesday, 1st May 2024 BHVN stock ended at $40.18. This is 3.56% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.34% from a day low at $38.43 to a day high of $41.64.
90 days $36.77 $62.21
52 weeks $13.03 $62.21

Historical Biohaven Pharmaceutical Holding Company Ltd prices

Date Open High Low Close Volume
Jan 12, 2024 $45.98 $46.84 $45.24 $45.34 629 689
Jan 11, 2024 $46.00 $46.13 $43.70 $45.46 1 140 084
Jan 10, 2024 $47.96 $48.29 $46.08 $46.50 985 336
Jan 09, 2024 $46.53 $48.66 $45.55 $47.71 1 399 736
Jan 08, 2024 $42.92 $47.17 $42.92 $47.06 2 027 581
Jan 05, 2024 $41.50 $43.74 $41.15 $42.59 1 024 636
Jan 04, 2024 $40.56 $43.83 $40.56 $42.36 837 157
Jan 03, 2024 $41.31 $42.39 $39.84 $40.19 790 188
Jan 02, 2024 $42.09 $42.69 $40.35 $41.93 1 106 312
Dec 29, 2023 $42.89 $43.44 $41.74 $42.80 904 221
Dec 28, 2023 $43.67 $44.20 $42.91 $43.28 787 948
Dec 27, 2023 $43.41 $44.21 $42.90 $43.76 797 815
Dec 26, 2023 $41.48 $43.31 $41.03 $43.28 1 287 507
Dec 22, 2023 $39.38 $40.97 $39.09 $40.08 1 641 806
Dec 21, 2023 $38.50 $39.20 $37.85 $38.02 1 072 676
Dec 20, 2023 $36.53 $39.66 $34.75 $37.92 1 819 389
Dec 19, 2023 $39.67 $40.23 $37.88 $38.36 1 369 607
Dec 18, 2023 $39.11 $39.77 $38.41 $39.04 717 679
Dec 15, 2023 $38.03 $39.55 $37.80 $39.00 1 354 816
Dec 14, 2023 $36.58 $37.98 $35.45 $37.65 1 343 278
Dec 13, 2023 $35.71 $36.32 $34.55 $36.15 1 050 697
Dec 12, 2023 $33.39 $36.17 $32.69 $35.75 1 369 103
Dec 11, 2023 $33.00 $33.64 $32.08 $33.61 911 337
Dec 08, 2023 $33.50 $34.49 $32.89 $33.06 1 067 428
Dec 07, 2023 $33.28 $33.79 $32.89 $33.01 708 746
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT